Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Irreversible Electroporation Ablation for Postoperative Recurrent or Metastatic Cervical Lymph Node Disease in Thyroid Cancer: A Prospective, Multicenter, Single-Arm, Exploratory Clinical Trial

NCT07328243 is registered in ClinicalTrials.gov with Tian'an Jiang as lead sponsor.

NCT NCT07328243
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07328243 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Irreversible Electroporation Ablation for Postoperative Recurrent or Metastatic Cervical Lymph Node Disease in Thyroid Cancer: A Prospective, Multicenter, Single-Arm, Exploratory Clinical Trial
Lead sponsor
Tian'an Jiang
Phase
Not applicable
Overall status
Recruiting
Start date
December 17, 2025
Completion date
June 30, 2028
Enrollment
85 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

lymph node metastasis, thyroid cancer patients